Hello Scott, I am copying our CyTOF expert, Dr. Rahman. He can assist you. [MSMC_RGB_Hrztl] Reginald W. Miller, DVM, DACLAM Dean for Research-Operations and Infrastructure Chair, Diversity in Biomedical Research Council Senior Research Integrity Officer, MSHS Associate Professor, Comparative Med & Surgery Associate Professor, Environmental Med & Public Health Icahn School of Medicine at Mount Sinai New York, NY 10029<x-apple-data-detectors://1/0> E: <email obscured><email obscured>> P: 212.241.3008<tel:212.241.3008> On Mar 15, 2018, at 2:13 PM, Shaffer, Scott A. <email obscured><email obscured>>> wrote: Hi- My institution is interested in acquiring a CyTOF (Fluidigm Hyperion) for mass cytometry and imaging applications. I have seen multiple polished presentations on the technology and I would be interested to chat with any users in the field particularly from a core facility background (eg flow core or MS core) that are willing to share their experiences with this. I am most interested to hear about the sample prep/conjugation process and experiences on how well this has been implemented in facility work. Please contact me online or offline, your preference. Any shared experiences would be greatly appreciated. Scott- Scott Shaffer, Ph.D. Director, Mass Spectrometry Facility Professor, Biochemistry and Molecular Pharmacology University of Massachusetts Medical School 222 Maple Ave / Fuller Building Shrewsbury, MA 01545 508.856.8917 <email obscured><email obscured><email obscured>> ―― View topic https://urldefense.proofpoint.com/v2/url?u=http-3A__list.abrf.org_r_topic_7qZ39nSNyMd7KThHXTSAgx&d=DwIFaQ&c=shNJtf5dKgNcPZ6Yh64b-A&r=5SaxizafT3loYxeSMhs2P-TgKFTxH2t7wFNBuGJyTww&m=sI05GUgEHB2OjwDI3dPQvtkjD47b83U2UoPqBypkFA0&s=499XJpv4PS7njvl5knbRca8d3reZwrr_y4pNy1nWHOs&e= Leave group <email obscured>?Subject=Unsubscribe